One of the key components of NETs, ​​the DNA-histone complex, can recognize and bind to the transmembrane protein CCDC25 on breast cancer cells, thereby activating the ILK-β-parvin pathway to enhance tumor cell motility and lead tumor cells to form distant metastases (165). This evidence concerns the gene CCDC25 and breast carcinoma.